On January 14, 2021 Onconova Therapeutics, Inc. (NASDAQ: ONTX) ("Onconova"), a biopharmaceutical company focused on discovering and developing novel products for patients with cancer, reported that Steven Fruchtman, MD, President & CEO, will present a Company overview at NobleCon17, Noble Capital Markets Seventeenth Annual Small and Microcap Investor Conference being held virtually January 19th and 20th (Press release, Onconova, JAN 14, 2021, View Source [SID1234574018]). The conference is virtual, with no cost, obligation, or restrictions to attend: www.noblecon17.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details

Date: Wednesday, January 20th at 4:30p EST (Track 1)

20-minute presentation
20-minute live video breakout / Q&A immediately following the scheduled presentation
A high-definition video webcast of the presentation will be available the following day on the Company’s website (www.onconova.com), and as part of a complete catalog of presentations to be rebroadcast on Channelchek (www.channelchek.com) next month.